Eli Lilly discovers, develops and manufactures medicines. Diabetes and obesity, cancer, immunology and neuroscience are its focus areas, with treatments that include Mounjaro and Zepbound (tirzepatide), Trulicity, several insulins and the Alzheimer's drug Kisunla, prescribed to patients across dozens of nations. Colonel Eli Lilly, a pharmacist and Civil War veteran, opened his laboratory in Indianapolis in 1876, and in 1923 Lilly was first to sell insulin commercially, working with the Toronto researchers who had isolated it.
Eli Lilly and Company is listed on the New York Stock Exchange under the ticker LLY. It is part of the Healthcare sector, in the Drug Manufacturers - General industry, and is based in Indianapolis, United States.
This page opens SwinGrowth's analysis of Eli Lilly from its real daily price history: an entry zone, a stop loss and two price targets for a swing trade, with its trend, RSI, moving averages, volume, support and resistance.
Other Healthcare stocks on SwinGrowth: Johnson & Johnson, AbbVie and Merck.
Education, not financial advice. SwinGrowth does not predict prices or tell you to buy or sell.